Episodes 136-150 of 762
Diagnosing Duchenne Muscular Dystrophy: Recognizing Signs and Reducing Delays
NeuroFrontiersDiagnosing Duchenne Muscular Dystrophy: Recognizing Signs and Reducing Delays
Duchenne Muscular Dystrophy Management: Analyzing Current Approaches
NeuroFrontiersDuchenne Muscular Dystrophy Management: Analyzing Current Approaches
From Trials to Practice: Evaluating Xanomeline-Trospium Chloride for Schizophrenia
NeuroFrontiersFrom Trials to Practice: Evaluating Xanomeline-Trospium Chloride for Schizophrenia
Exploring Metabolomics in Multiple Sclerosis
NeuroFrontiersExploring Metabolomics in Multiple Sclerosis
Metabolomics in Multiple Sclerosis: Advancing Diagnosis, Prognosis, and Treatment Response
NeuroFrontiersMetabolomics in Multiple Sclerosis: Advancing Diagnosis, Prognosis, and Treatment Response
Safety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
NeuroFrontiersSafety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
- advertisement
MS and the Ketogenic Diet: Potential Impacts on Inflammation and Relapse
NeuroFrontiersMS and the Ketogenic Diet: Potential Impacts on Inflammation and Relapse
Managing Multiple Sclerosis: The Impact of Dietary Modifications
On the Frontlines of Multiple SclerosisManaging Multiple Sclerosis: The Impact of Dietary Modifications
Strategies and Considerations for Managing MS in Pregnant Women
On the Frontlines of Multiple SclerosisStrategies and Considerations for Managing MS in Pregnant Women
Cognitive Impairment in MS: Mitigating Impacts to Optimize Brain Health
NeuroFrontiersCognitive Impairment in MS: Mitigating Impacts to Optimize Brain Health
Understanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
NeuroFrontiersUnderstanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
Emerging Technologies in MS: Neuromodulation and Myelin Regeneration
NeuroFrontiersEmerging Technologies in MS: Neuromodulation and Myelin Regeneration
- advertisement
MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
NeuroFrontiersMS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
Multiple Sclerosis Explained: Understanding Its Epidemiology
NeuroFrontiersMultiple Sclerosis Explained: Understanding Its Epidemiology
Generalized Myasthenia Gravis Management: Evaluating Long-Term Effects
NeuroFrontiersGeneralized Myasthenia Gravis Management: Evaluating Long-Term Effects
